Skip to main content
CATCongressional Accountability Tracker
OfficialsLegislationCommitteesWatch LivePulseForecastMisconductPresidentLearn
CAT

Congressional Accountability Tracker. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Forecast

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live
  • About This Site

Data Sources

Congress.gov
Bills, members, votesGovInfo
Floor speeches, reports, bill textFederal Election Commission
Campaign financeVoteView
Ideology scores (DW-NOMINATE)GovTrack
Misconduct data (CC0)U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Congressional Accountability Tracker

HR4101Referred to Committee

Cancer Drug Parity Act of 2025

Share:
Introduced
2
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-06-24
Introduced
27
Cosponsors
HR
ⓘ
Type

Sponsor

Glenn Grothman
Glenn Grothman
Republican · WI · Representative

Latest Action

Referred to the House Committee on Education and Workforce.

2025-06-24

Bill Summary

This bill, known as the Cancer Drug Parity Act of 2025, addresses Cancer Drug Parity Act of 2025. It has been referred to committee for review and possible markup.

Subjects

Health
Read the full bill text
Read Full TextCongress.gov